His lab is working on refining the alanine-scanning assay to a few crucial residues that can accurately distinguish between fibrils from neurodegenerative tauopathies. He envisions using this streamlined assay for postmortem neuropathological diagnosis, and possibly for blood screening of tauopathies.Immerse you in TAU’s bold and emotionally char